Dein erstes Forum » Lee's Pharmaceutical Holdings Limited 32

Latest Report On Ocular Hypertension - Pipeline Review N'Keal Harry Rush Jersey , H1 Market Trends, Size, Drivers Report 2016 Health Articles | April 28, 2016

The report " Ocular Hypertension - Pipeline Review Jarrett Stidham Rush Jersey , H1 2016 ”, has been prepared based on an in-depth market analysis with inputs from industry experts.



聽


Global Markets Directs, Ocular Hypertension - Pipeline Review, H1 2016 Sony Michel Rush Jersey , provides an overview of the Ocular Hypertension pipeline landscape.


The report provides comprehensive information on the therapeutics under development for Ocular Hypertension, complete with analysis by stage of development, drug target, mechanism of action (MoA) Stephon Gilmore Rush Jersey , route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Ocular Hypertension and features dormant and discontinued projects.


Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Directs proprietary databases Tom Brady Rush Jersey , companyuniversity websites, clinical trial registries, conferences, SEC filings Julian Edelman Rush Jersey , investor presentations and featured press releases from companyuniversity sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.


The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.


Download Sample copy of this Report at :

Scope


The report provides a snapshot of the global therapeutic landscape of Ocular Hypertension


The report reviews pipeline therapeutics for Ocular Hypertension by companies and universitiesresearch institutes based on information derived from company and industry-specific sources


The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages


The report features descriptive drug profiles for the pipeline products which includes, product description Jake Bailey Jersey , descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities


The report reviews key players involved Ocular Hypertension therapeutics and enlists all their major and minor projects


The report assesses Ocular Hypertension therapeutics based on drug target, mechanism of action (MoA) Hjalte Froholdt Jersey , route of administration (RoA) and molecule type


The report summarizes all the dormant and discontinued pipeline projects


The report reviews latest news related to pipeline therapeutics for Ocular Hypertension


Reasons to buy


Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies


Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage


Identify and understand important and diverse types of therapeutics under development for Ocular Hypertension


Identify potential new clients or partners in the target demographic


Develop strategic initiatives by understanding the focus areas of leading companies


Plan mergers and acquisitions effectively by identifying key players and its most promising pipeline therapeutics


Devise corrective measures for pipeline projects by understanding Ocular Hypertension pipeline depth and focus of Indication therapeutics


Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope


Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline


Browse Latest News at

Table of Contents


Table of Contents 2


List of Tables 7


List of Figures 8


Introduction 9


Global Markets Direct Report Coverage 9


Ocular Hypertension Overview 10


Therapeutics Development 11


Pipeline Products for Ocular Hypertension - Overview 11


Pipeline Products for Ocular Hypertension - Comparative Analysis 12


Ocular Hypertension - Therapeutics under Development by Companies 13


Ocular Hypertension - Therapeutics under Investigation by UniversitiesInstitutes 15


Ocular Hypertension - Pipeline Products Glance 16


Late Stage Products 16


Clinical Stage Products 17


Early Stage Products 18


Ocular Hypertension - Products under Development by Companies 19


Ocular Hypertension - Products under Investigation by UniversitiesInstitutes 21


Ocular Hypertension - Companies Involved in Therapeutics Development 22


Aerie Pharmaceuticals, Inc. 22


Allergan Plc 23


Amakem NV 24


Asahi Kasei Pharma Corp. 25


Bausch & Lomb Incorporated 26


Can-Fite BioPharma Ltd. 27


D. Western Therapeutics Institute Yodny Cajuste Jersey , Inc. 28


F. Hoffmann-La Roche Ltd. 29


Inotek Pharmaceuticals Corporation 30


Kowa Company, Ltd. 31


Lee's Pharmaceutical Holdings Limited 32


NicOx S.A. 33


Ocular Therap>Wireless Broadband Network Technology for easy access of Inte. Wholesale NFL Shirts Wholesale NCAA Jerseys Wholesale College Hoodies Wholesale Basketball Shirts Wholesale Nike NBA Hoodies Wholesale MLB Hats China Cheap Nike NBA Hats Wholesale College Hats Cheap Soccer Jerseys Wholesale Wholesale MLB Jerseys